Skip to main navigation Skip to search Skip to main content

ONE-YEAR RANDOMISED CONTROLLED TRIAL OF SECOND LINE AGENTS IN MYOSITIS (SELAM): ADDITIONAL IMMUNOSUPPRESSION IS INEFFECTIVE IN PATIENTS WHO HAVE PARTIALLY RESPONDED TO STEROIDS

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)33 - 34
Number of pages2
JournalRheumatology
Volume50
Publication statusPublished - 2011

Cite this